EP 2988735 A1 20160302 - PHARMACEUTICAL COMPOSITION COMPRISING A DUAL REUPTAKE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF
Title (en)
PHARMACEUTICAL COMPOSITION COMPRISING A DUAL REUPTAKE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT DUALEM WIEDERAUFNAHMEHEMMER UND VERFAHREN ZUR HERSTELLUNG DAVON
Title (fr)
COMPOSITION PHARMACEUTIQUE COMPRENANT UN INHIBITEUR DE RÉABSORPTION DOUBLE ET PROCÉDÉ DE PRÉPARATION CORRESPONDANT
Publication
Application
Priority
- GR 20130100262 A 20130423
- EP 2014001041 W 20140417
Abstract (en)
[origin: WO2014173516A1] The present invention relates to a stable pharmaceutical formulation for oral administration comprising a therapeutically effective amount of a serotonin-norepinephrine reuptake inhibitor or a pharmaceutically acceptable salt thereof, in particular Duloxetine that inhibits degradation and/or hydrolysis of the active ingredient. It also relates to a process for the preparation thereof.
IPC 8 full level
A61K 9/48 (2006.01); A61K 9/28 (2006.01); A61K 31/381 (2006.01)
CPC (source: EP GR)
A61K 9/2886 (2013.01 - GR); A61K 9/4808 (2013.01 - EP GR); A61K 9/4858 (2013.01 - EP); A61K 9/4866 (2013.01 - EP); A61K 31/381 (2013.01 - EP GR); A61P 25/24 (2017.12 - EP)
Citation (search report)
See references of WO 2014173516A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2014173516 A1 20141030; DK 2988735 T3 20200831; EP 2988735 A1 20160302; EP 2988735 B1 20200624; ES 2814965 T3 20210329; GR 1008228 B 20140616; HU E051902 T2 20210329; PL 2988735 T3 20210308
DOCDB simple family (application)
EP 2014001041 W 20140417; DK 14718330 T 20140417; EP 14718330 A 20140417; ES 14718330 T 20140417; GR 20130100262 A 20130423; HU E14718330 A 20140417; PL 14718330 T 20140417